Dupont Capital Management Corp Xencor Inc Transaction History

Dupont Capital Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 29, 2020	SELL	$20.69 - $37.79 $208,120 - $380,129	-10,059 Closed	0 $0
Q3 2019 Oct 28, 2019	BUY	$33.73 - $46.27 $339,290 - $465,429	10,059 New	10,059 $339,000
Q4 2017 Jan 31, 2018	SELL	$19.29 - $24.83 $804,643 - $1.04 Million	-41,713 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$19.61 - $23.35 $817,991 - $973,998	41,713	41,713 $956,000

214

71.8M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.09B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.